Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Ablation Equipments - Medical Devices Pipeline Assessment, 2016

Be the first to review this product

Ablation Equipments - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Ablation Equipments - Medical Devices Pipeline Assessment, 2016' provides an...
You can choose to pay by purchase order during checkout

Availability: In stock

$2,500.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Ablation Equipments - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, 'Ablation Equipments - Medical Devices Pipeline Assessment, 2016' provides an overview of Ablation Equipments currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ablation Equipments pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ablation Equipments under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ablation Equipments and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ablation Equipments under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 95
Publication date 15 Apr 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Ablation Equipments Overview 8
3 Products under Development 9
3.1 Ablation Equipments - Pipeline Products by Stage of Development 9
3.2 Ablation Equipments - Pipeline Products by Territory 10
3.3 Ablation Equipments - Pipeline Products by Regulatory Path 11
3.4 Ablation Equipments - Pipeline Products by Estimated Approval Date 12
3.5 Ablation Equipments - Ongoing Clinical Trials 13
4 Ablation Equipments - Pipeline Products under Development by Companies 14
4.1 Ablation Equipments Companies - Pipeline Products by Stage of Development 14
4.2 Ablation Equipments - Pipeline Products by Stage of Development 15
5 Ablation Equipments Companies and Product Overview 16
5.1 AngioDynamics, Inc. Company Overview 16
5.1.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 AtriCure, Inc. Company Overview 27
5.2.1 AtriCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.3 CPSI Biotech Company Overview 29
5.3.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 29
5.4 EP Global Communications, Inc. Company Overview 31
5.4.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 HistoSonics, Inc. Company Overview 33
5.5.1 HistoSonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.6 Hospital for Special Surgery Company Overview 36
5.6.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Innoblative Designs, Inc. Company Overview 37
5.7.1 Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 Integra LifeSciences Holdings Corporation Company Overview 40
5.8.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
5.9 Intratherm, Llc Company Overview 42
5.9.1 Intratherm, Llc Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Medtronic plc Company Overview 43
5.10.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Memorial Sloan Kettering Cancer Center Company Overview 51
5.11.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 51
5.12 Mirabilis Medical, Inc. Company Overview 53
5.12.1 Mirabilis Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Prosurg, Inc. Company Overview 55
5.13.1 Prosurg, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.14 Smith & Nephew Plc Company Overview 57
5.14.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 57
5.15 Thermedical, Inc. Company Overview 59
5.15.1 Thermedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.16 TransEnterix, Inc. Company Overview 61
5.16.1 TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.17 University of California, San Francisco Company Overview 62
5.17.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 62
5.18 University of Texas at Austin Company Overview 63
5.18.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 63
5.19 University of Wisconsin-Stout Company Overview 64
5.19.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview 64
6 Ablation Equipments- Recent Developments 66
6.1 Mar 22, 2016: Kim Bridges joins Halt Medical as President and Chief Executive Officer 66
6.2 Mar 21, 2016: CSA Medical Announces the First Presentation of the RejuvenAir System Metered Cryospray Clinical Data 66
6.3 Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance 67
6.4 Feb 25, 2016: Integra LifeSciences Announces Service Alliance Agreement With PREZIO Health 68
6.5 Feb 09, 2016: Misonix Announces Second Quarter Fiscal Year 2016 Financial Results 69
6.6 Jan 13, 2016: Medtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool RF Ablation System 70
6.7 Dec 22, 2015: Galil Medical Terminates Acquisition of Perseon for up to USD10.6 Million 71
6.8 Dec 18, 2015: Relievant Medsystems Raises USD1.5 Million in Venture Financing 71
6.9 Dec 16, 2015: Medtronic Acquires OsteoCool RF Ablation System from Baylis Medical 71
6.10 Dec 15, 2015: DFINE Announces Commercial Launch of the Long SpineSTAR Ablation Instrument for the Palliative Treatment of Metastatic Spine Tumors 71
6.11 Nov 26, 2015: Google Files For Patent For Laser Ablation Surgical System 72
6.12 Nov 10, 2015: C2 Therapeutics Announces New Data Confirming Efficacy and Safety of Coldplay CryoBalloon Focal Ablation System to Treat Esophageal Disease 72
6.13 Nov 05, 2015: Misonix Announces First Quarter Fiscal Year 2016 Financial Results 73
6.14 Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results 74
6.15 Oct 30, 2015: Integra LifeSciences Receives Expanded Indication for CUSA Excel+ System for Liver Surgery 75
6.16 Oct 15, 2015: AngioDynamics Announces the Approval of the NanoKnife System in South Korea 75
6.17 Sep 15, 2015: Perseon Announces New Data for MicroThermX in the Treatment of Large Liver Metastases From Colorectal Cancer and Large Hepatocellular Carcinoma From 2015 SICO Conference 76
6.18 Aug 31, 2015: Perseon Announces the Initiation of the First Multi-Organ in vivo Ablation Zone Study for MicroThermX in Laparoscopic and Open Approaches 76
6.19 Aug 31, 2015: Integra LifeSciences Raises USD220 Million in Public Offering of Shares 77
6.20 Aug 20, 2015: Misonix Announces Fourth Quarter And Fiscal Year End 2015 Financial Results 77
6.21 Aug 19, 2015: Perseon Launches INSPIRE 2017, a Dramatic Effort to Increase Adoption of Microwave Ablation to Fight Cancer 79
6.22 Aug 13, 2015: Research Data Published in Annals of Surgery Concludes Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer Compared With Historical Controls 80
6.23 Aug 06, 2015: Perseon Announces Data Presented at the American Association of Physicists in Medicine Meeting Supporting the Use of Microwave Ablation 80
6.24 Aug 04, 2015: Perseon Announces a User Enhancement Upgrade for Energy Ablation System MicroThermX 81
6.25 Aug 04, 2015: Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million 81
6.26 Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results 82
6.27 Jul 29, 2015: C2 Therapeutics Receives FDA 510(k) Clearance for the Coldplay Full CryoBalloon Ablation System 83
6.28 Jul 29, 2015: C2 Therapeutics Receives FDA 510(k) Clearance for the Coldplay Swipe CryoBalloon Ablation System 83
6.29 Jul 20, 2015: C2 Therapeutics Announces Successful Safety and Dosing Results of Coldplay Cryoballoon Focal Ablation System in International Trial 83
6.30 Jul 16, 2015: Cianna Medical Raises USD4 Million in Venture Financing Round 84
6.31 Jul 09, 2015: SonaCare Medical Sells Prostate Ablation System with MRI/Ultrasound Image Fusion to Heidelberg Prostate Clinic 84
6.32 Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine 85
6.33 May 18, 2015: CSA Medical Announces Publication of Results of National Cryospray Registry in Diseases of the Esophagus 85
6.34 May 07, 2015: Misonix Announces Third Quarter Fiscal Year 2015 Financial Results 86
6.35 May 06, 2015: Perseon's MicroThermX to be Featured at WCIO 2015 Interventional Oncology Forum 87
6.36 May 06, 2015: NeuWave Medical Raises USD25 Million in Series C Financing 87
6.37 Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine 88
6.38 Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results 88
6.39 Apr 24, 2015: New Data Shows Irreversible Electroporation Nearly Doubles Overall Survival of Patients with Locally Advanced Pancreatic Cancer When Added to Standard Therapy 90
6.40 Apr 14, 2015: Perseon Announces FDA Clearance for Specific Indication of Non-Resectable Liver Tumor Ablation 91
7 Appendix 92
7.1 Methodology 92
7.2 About GlobalData 94
7.3 Contact Us 95
7.4 Disclaimer 95

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.